A shortage of mental health beds and poor communication between agencies contributed to the death of a teenage girl on hospital grounds, an inquest has found. Ellame Ford-Dunn, 16, who had a history of self-harm, died in March 2022 after absconding from an acute children’s ward where she had been put because of a dearth of appropriate mental health beds. Her family and campaigners say Ellame’s dea...
A shortage of mental health beds and poor communication between agencies contributed to the death of a teenage girl on hospital grounds, an inquest has found. Ellame Ford-Dunn, 16, who had a history of self-harm, died in March 2022 after absconding from an acute children’s ward where she had been put because of a dearth of appropriate mental health beds. Her family and campaigners say Ellame’s death exposed a mental health system “crumbling at the seams”. The inquest jury at West Sussex coroner’s court was told that Ellame absconded “multiple times” during her stay at Worthing hospital’s Bluefin ward, which was not a specialist mental health unit. Jurors concluded the decision to place Ellame there was “inappropriate” and “more than minimally” contributed to her death. They found “inadequate provision” of mental health beds also contributed to her death. The coroner, Joanne Andrews, said she would issue a prevention of future deaths report to warn that more children would die unless the inadequate provision of mental health beds was tackled. Ellame’s parents Ken and Nancy Ford-Dunn urged the government to increase funding for mental health services to ensure “other families don’t have to experience the worst thing imaginable”. When Ellame absconded she was not immediately followed by staff, because they were not allowed to chase patients out of the ward, the inquest heard. It took 59 minutes for her to be found by police, the jury was told. University hospitals Sussex (UHSussex), which runs the acute ward, was fined £200,000 last year in a separate prosecution over Ellame’s death. Her mental health care was provided by Sussex partnership NHS foundation trust (SPFT). Jurors concluded that “poor coordination, communication and accountability” between “multiple agencies” also contributed to Ellame’s death. “Inconsistency in nursing handovers” and a lack of guidance for staff were another factor in her death, they found. The jury foreman said: “The instructions given to...
I recently described in a Barchart article why Microsoft Corp (MSFT) stock looks cheap here, despite the market's concerns about its free cash flow (FCF). My price target is $521, or 23% higher over the next year. One play for value investors is to sell short at-the-money and out-of-the-money put options with one-month expiration periods. MSFT is down today at $424.53 per share, well off its recen...
I recently described in a Barchart article why Microsoft Corp (MSFT) stock looks cheap here, despite the market's concerns about its free cash flow (FCF). My price target is $521, or 23% higher over the next year. One play for value investors is to sell short at-the-money and out-of-the-money put options with one-month expiration periods. MSFT is down today at $424.53 per share, well off its recent Jan. 28 peak of $481.63, before its market close release of fiscal Q2 earnings on the same day. This is a near-12 % decline over several days that seems overdone. Upside Potential My Jan. 30 Barchart article discussed this ("Microsoft's Free Cash Flow Crashes Due to High Capex - But Is MSFT Stock's Dip Overdone?"). I showed why Microsoft's FCF could reach $86 billion over the next 12 months (NTM), and this could give Microsoft a $3.87 trillion market cap. That is 22.66% higher than today's market cap of $3.155 trillion, according to Yahoo! Finance. In other words, MSFT could be worth: $424.53 stock price x 1.2266 = $520.73 per share Upside: +23% Other analysts are also optimistic. Yahoo! Finance's survey of 57 analysts' price targets (PTs) is $599.58. That's +41% higher than today's depressed stock price. Similarly, Barchart's mean survey price target (PT) is $604.46. However, AnaChart.com, which tracks recent stock analysts' write-ups, shows that the average PT of 29 analysts is $511.78. That still implies upside of 20.6% from today. So, along with me, most analysts are bullish over the long-term. That does not mean MSFT stock couldn't keep falling in the near term. This prospect has elevated put option premiums. That makes it profitable for value investors to sell short puts in one-month expiration periods. Shorting MSFT Puts This play allows investors to set a lower potential buy-in point for MSFT stock and also get paid while waiting. For example, look at the March 6, 2026, option expiration period, 32 days to expiry (DTE). It shows that the $410.00 put option exercis...
The US Department of Labor headquarters building is seen at dusk on June 21, 2024 in Washington, DC. J. David Ake | Getty Images News | Getty Images The Bureau of Labor Statistics will not be releasing the January jobs report as scheduled Friday due to the government shutdown, a department spokesman confirmed Monday. "The Employment Situation release for January 2026 will not be released as schedu...
The US Department of Labor headquarters building is seen at dusk on June 21, 2024 in Washington, DC. J. David Ake | Getty Images News | Getty Images The Bureau of Labor Statistics will not be releasing the January jobs report as scheduled Friday due to the government shutdown, a department spokesman confirmed Monday. "The Employment Situation release for January 2026 will not be released as scheduled on Friday, February 6, 2026. The release will be rescheduled upon the resumption of government funding," Emily Liddel, associate commissioner of the BLS, said in a statement. Following last year's record shutdown that stretched into early November, the bureau also was forced to delay a number of its routine releases and was just catching up from that incident. The BLS also releases the consumer price index, import and export data and multiple other labor- and consumer-related data pieces. It was not known if the Commerce Department also would face delays in its reporting due to the impasse in Washington. The decision comes ahead of a busy week for economic data that would have culminated with the nonfarm payrolls release, also known as the unemployment situation. The report provides a count of how many hires businesses report, which provides the headline nonfarm payrolls count, as well as a household count of how many people report holding jobs, which is used to tabulate the unemployment rate. Markets had been expecting the report to show an increase of 55,000 jobs and the unemployment rate to hold steady at 4.4%. The government closed its doors again Saturday after Congress was unable to come up with a spending plan by the deadline. One of the sticking points in the bill was funding for the Department of Homeland Security following unrest over its efforts to stem illegal immigration. House Speaker Mike Johnson (R-La.) said over the weekend that he expects the impasse could be resolved by Tuesday.
JHVEPhoto Seeking Alpha's roundup of statements, announcements, and remarks that could impact markets, sectors, or individual stocks. The U.S. and India have finally reached a trade deal. "Out of friendship and respect for Prime Minister Modi and, as per his request, effective immediately, we agreed to a Trade Deal between the United States and India, whereby the United States will charge a reduce...
JHVEPhoto Seeking Alpha's roundup of statements, announcements, and remarks that could impact markets, sectors, or individual stocks. The U.S. and India have finally reached a trade deal. "Out of friendship and respect for Prime Minister Modi and, as per his request, effective immediately, we agreed to a Trade Deal between the United States and India, whereby the United States will charge a reduced Reciprocal Tariff, lowering it from 25% to 18%. They will likewise move forward to reduce their Tariffs and Non-Tariff Barriers against the United States to ZERO," Trump said in a long post on Truth Social . "The Prime Minister also committed to “BUY AMERICAN,” at a much higher level, in addition to over $500 BILLION DOLLARS of U.S. Energy, Technology, Agricultural, Coal, and many other products. Our amazing relationship with India will be even stronger going forward," Trump added. Trump also said that India has agreed to stop buying Russian oil and buy more oil from the U.S. and potentially Venezuela. Disney ( DIS ) CEO Bob Iger, who is slated to step down at the end of the year, told investors Monday that the entertainment company was on a "path to continued growth." “I’m incredibly proud of all that we’ve accomplished over the past three years to set Disney on the path to continued growth. I’m inspired and energized by the opportunities ahead for this wonderful company,” Iger said during a conference call with investors, according to CNBC . Disney reported better-than-expected fiscal Q1 earnings early Monday. On Friday, The Wall Street Journal reported that Iger would like to step down as CEO before his contract expires at the end of 2026. Josh D’Amaro, who oversees Disney's theme parks and resorts division, is believed to be a frontrunner for the job. Disney's board is expected to vote on Iger's successor later this week, according to CNBC. Devon Energy ( DVN ) and Coterra Energy ( CTRA ) have agreed to merge through an all-stock deal with an enterprise value of aroun...
Another big week for tech earnings kicks off with investors eyeing the impact of circular AI deals and spending. Natalie Gallagher, principal economist and director at Board, joins Caroline Hyde on “Bloomberg Tech.” (Source: Bloomberg)
Another big week for tech earnings kicks off with investors eyeing the impact of circular AI deals and spending. Natalie Gallagher, principal economist and director at Board, joins Caroline Hyde on “Bloomberg Tech.” (Source: Bloomberg)
Donald Trump has announced he is cutting tariffs on India after prime minister Narendra Modi agreed to stop buying Russian oil. After a call with Modi on Monday, Trump on Truth Social said: “This will help END THE WAR in Ukraine, which is taking place right now, with thousands of people dying each and every week!” India is the second largest purchaser of Russian crude and the imports have increase...
Donald Trump has announced he is cutting tariffs on India after prime minister Narendra Modi agreed to stop buying Russian oil. After a call with Modi on Monday, Trump on Truth Social said: “This will help END THE WAR in Ukraine, which is taking place right now, with thousands of people dying each and every week!” India is the second largest purchaser of Russian crude and the imports have increased tensions between the two countries. Trump said that India, as agreeing to stop buying Russian oil, would also buy more oil from the United States and potentially Venezuela. “Out of friendship and respect for Prime Minister Modi and, as per his request, effective immediately, we agreed to a Trade Deal between the United States and India, whereby the United States will charge a reduced Reciprocal Tariff, lowering it from 25% to 18%,” Trump said in a Truth Social media post after a call with Modi. Modi also committed to buy more than $500bn dollars worth of US energy, technology, agricultural and other products, Trump added. “Our amazing relationship with India will be even stronger going forward. Prime Minister Modi and I are two people that GET THINGS DONE, something that cannot be said for most. Thank you for your attention to this matter!” wrote Trump. Reuters contributed reporting
Oracle Health Clinical AI Agent now supports clinicians with automated order creation in the U.S. Building upon its note generation functionality, this new capability uses ambient listening during appointments to draft highly accurate clinical orders, including laboratory tests, imaging and diagnostic studies, new and refilled prescription medications, and follow-up appointments. With Oracle Healt...
Oracle Health Clinical AI Agent now supports clinicians with automated order creation in the U.S. Building upon its note generation functionality, this new capability uses ambient listening during appointments to draft highly accurate clinical orders, including laboratory tests, imaging and diagnostic studies, new and refilled prescription medications, and follow-up appointments. With Oracle Health Clinical AI Agent order creation, healthcare providers can more efficiently create complete and accurate records while limiting the administrative burden on clinicians to reduce burnout and support better patient interactions. Healthcare providers face significant administrative burden from repetitive manual tasks, such as entering clinical orders for medications, labs, and referrals, which often pull them away from direct patient care. Oracle Health Clinical AI Agent helps solve this problem by analyzing discussions between patients and providers and capturing the clinician’s orders for next-step actions in the patient’s care, making it easy for physicians to review and approve. The solution uses advanced reasoning that evaluates previous order activity, patient order history, physician ordering favorites, and organizational ordering preferences to complete contextually appropriate orders for the patient. “From supporting clinicians with greater intelligence at the point of care to reducing the administrative burdens that drive up costs and increase burnout to fueling medical breakthroughs that can accelerate the delivery of lifesaving therapies to patients that need them, Oracle Health is using AI to drive transformation across the healthcare industry,” said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. “These new clinical order capabilities are another step in our journey to an AI-powered healthcare system that works for patients, providers, and payers alike.” Oracle’s Clinical AI agents don’t just interpret text; they use ...
Key Points This ETF has rising rates protection in its DNA. Despite its name, it can thrive even if rates don’t rise. It has some other traits likely to surprise dividend investors. 10 stocks we like better than Fidelity Covington Trust - Fidelity Dividend ETF For Rising Rates › Much to the dismay of the White House, some corners of Wall Street, and plenty of retail investors, the Federal Reserve ...
Key Points This ETF has rising rates protection in its DNA. Despite its name, it can thrive even if rates don’t rise. It has some other traits likely to surprise dividend investors. 10 stocks we like better than Fidelity Covington Trust - Fidelity Dividend ETF For Rising Rates › Much to the dismay of the White House, some corners of Wall Street, and plenty of retail investors, the Federal Reserve held interest rates unchanged this past Wednesday, dashing hopes of a January rate cut. One meeting without a rate cut doesn't mean the central bank is suddenly turning hawkish and that monetary tightening is imminent. But for the sake of argument, let's consider the possibility that the macroeconomic environment rapidly shifts to the point that the Fed is backed into a corner and must raise rates. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » There's an exchange-traded fund (ETF) for that, and it's the Fidelity Dividend ETF For Rising Rates (NYSEMKT: FDRR). Yes, this ETF protects in the event that 10-year Treasury yields rise, but even if that doesn't happen, the fund offers utility. Rates up, rates down, this ETF can deliver This $660 million Fidelity ETF follows an index of the same name. That gauge is "designed to reflect the performance of stocks of large and mid-capitalization dividend-paying companies that are expected to continue to pay and grow their dividends and have a positive correlation of returns to increasing 10-year U.S. Treasury yields," according to the issuer. Dispensing with the financial jargon, some sectors can thrive even when those yields rise. Other sectors are considered rate-sensitive in a negative fashion. Historically, REITs and utilities have been in the latter category due to their capital-intensive nature. So, it's not surprising that the real estate and utilities sectors combine for just 4.1% of this ETF's roster. The ...
Trump Slashes India Tariffs After Modi Agrees To Drop Russian Oil, Go Full 'BUY AMERICAN' In a huge Monday development, President Trump has announced the US will trim its punitive 25% tariff on Indian imports to 18% after striking what he hailed as a new "trade deal” with Indian Prime Minister Narendra Modi. Crucially it hinges on New Delhi having reportedly ended its purchases of Russian crude an...
Trump Slashes India Tariffs After Modi Agrees To Drop Russian Oil, Go Full 'BUY AMERICAN' In a huge Monday development, President Trump has announced the US will trim its punitive 25% tariff on Indian imports to 18% after striking what he hailed as a new "trade deal” with Indian Prime Minister Narendra Modi. Crucially it hinges on New Delhi having reportedly ended its purchases of Russian crude and swapping them for massive US energy and goods buys . In a Truth Social post, Trump portrayed the agreement as a major geopolitical win, saying that India "agreed to stop buying Russian oil, and to buy much more from the United States and, potentially, Venezuela," and crucially framing the move as helping "END THE WAR in Ukraine." via AP Under the newly touted deal, according to breaking details.: The United States will cut its "reciprocal tariff" on Indian goods from 25% to 18%, effective immediately. India will slash its tariffs and non-tariff barriers on American products to zero. Modi has pledged a gargantuan "BUY AMERICAN" commitment , including upwards of $500 billion in U.S. energy, technology, farm, coal, and other exports. Trump cast the concessions as evidence of deep bilateral "friendship and respect," insisting the deal marks a new chapter in US–India trade and energy ties. This will of course also be a blow to Moscow's oil lifeline. Bloomberg notes: The White House did not immediately respond to a request for comment on if Trump was lowering the reciprocal tariff and eliminating the extra penalty over Russian oil purchases, or simply reducing one of the rates. India’s benchmark stock index Nifty 50’s futures traded at the Gujarat International Fin-Tec City surged as much as 3.8% in thin trading, while the US-listed iShares MSCI India ETF hit session highs and rose as much as 2.4%. The rupee rallied in ofshore trading, gaining 1% against the dollar. The shift represents a dramatic retreat from the brash tariff escalation of 2025, when Washington first slapped I...
JHVEPhoto Covetrus, a private-equity-backed tech company for veterinary practices, is in preliminary talks to purchase Cencora Inc.'s veterinary business, according to a Bloomberg report from late Friday. Covetrus’ owners, Clayton Dubilier & Rice and TPG Inc. ( TPG ), are in talks with private credit firms including Blue Owl Capital to line up new debt for the company, Bloomberg has previously rep...
JHVEPhoto Covetrus, a private-equity-backed tech company for veterinary practices, is in preliminary talks to purchase Cencora Inc.'s veterinary business, according to a Bloomberg report from late Friday. Covetrus’ owners, Clayton Dubilier & Rice and TPG Inc. ( TPG ), are in talks with private credit firms including Blue Owl Capital to line up new debt for the company, Bloomberg has previously reported. The ~$3 billion of financing would be used to refinance Covetrus’ $2 billion of existing debt and to help fund the potential purchase of the vet business. CD&R, TPG, Cencora, and Blue Owl declined to comment to Bloomberg. A representative for Covetrus didn't immediately respond to requests for comment. CD&R and TPG took Covetrus private in 2022 in a deal that the valued the company at about $4 billion. More on Cencora Cencora: High-Growth Specialty Services Firm Disguised As A Distributor Cencora, Inc. (COR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Cencora, Inc. (COR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Cencora upgraded as Morgan Stanley cites a “golden era” for drug distributors Trump unveils 'Great Healthcare Plan' to lower drug prices, premiums
Crystal Palace striker Jean-Philippe Mateta's move to AC Milan is off because of issues with his medical. But Palace are still set to sign Wolves forward Jorgen Strand Larsen in a £48m deal before Monday's 19:00 GMT transfer deadline. France forward Mateta, who has been nursing a knee issue, had an initial medical examination on Sunday followed by additional tests on Monday. The Italian club have ...
Crystal Palace striker Jean-Philippe Mateta's move to AC Milan is off because of issues with his medical. But Palace are still set to sign Wolves forward Jorgen Strand Larsen in a £48m deal before Monday's 19:00 GMT transfer deadline. France forward Mateta, who has been nursing a knee issue, had an initial medical examination on Sunday followed by additional tests on Monday. The Italian club have now pulled out of the £30m deal for the 28-year-old, who wants to leave Selhurst Park. Palace had been unwilling to let him go without having a replacement, but agreed a deal for Strand Larsen and granted Mateta permission to have an initial medical in London before flying to Milan. Nottingham Forest have also been interested in the striker and had a £35m bid rejected by Palace last weekend. After the 1-1 draw at Forest on Sunday, Palace manager Oliver Glasner said: "I expect either Mateta or someone else here as a striker. "Everybody is really working very hard, but it is so close to the end of the window, so it makes it more difficult. I always try to be positive, so I hope. "Worst case, we sell Mateta and no-one comes in, then it's not a good window for Palace."
Arsgera Eramet ( ERMAF ) ( ERMAY ) -11.5% in Monday's trading after the French mining company terminated the mandate of CEO Paulo Castellari and temporarily re-appointed Chairwoman Christel Bories to the role she had handed to Castellari last May. Eramet said on Sunday it had dismissed Castellari just months into his term due to disagreements over "operating methods" concerning "the processes of d...
Arsgera Eramet ( ERMAF ) ( ERMAY ) -11.5% in Monday's trading after the French mining company terminated the mandate of CEO Paulo Castellari and temporarily re-appointed Chairwoman Christel Bories to the role she had handed to Castellari last May. Eramet said on Sunday it had dismissed Castellari just months into his term due to disagreements over "operating methods" concerning "the processes of decision-making and coordination and interactions in exchanges between the board and the CEO," Bories said while declining to provide specific examples of issues that led to Castellari's termination. "This announcement comes as a shock," Oddo BHF analyst Maxime Kogge said in a note. "With his departure, Eramet enters another transition period that will make it harder to carry out much needed cost reductions and operational improvements." While Castellari's ouster likely was a joint decision, diverging interests between the major owners eager to maintain shareholder payouts and the French state focused on growth investments could be "a drag on the replacement process," Kogge also said. More on Eramet Eramet Discusses Safety Challenges and Operational Performance Improvements - Slideshow Seeking Alpha’s Quant Rating on Eramet